Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LEE011 + Chemoembolization in Advanced HCC
NCT02524119Phase 2Terminated
- Sponsor
- UT Southwestern Medical Center
- Start
- Apr 2016
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ribociclib in hepatocellular carcinoma (HCC), sponsored by UT Southwestern Medical Center. Started Apr 2016; status: terminated.
02
Drugs
ribociclib
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT02524119.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02524119.